Kelly & Windsor Proudly Supports the Jreissati Pancreatic Cancer Centre at Epworth
At Kelly & Windsor, we believe that doing good business means doing good — full stop. That's why we're proud to support the Jreissati Pancreatic Cancer Centre at Epworth, one of Melbourne's leading dedicated centres for pancreatic cancer research, clinical trials and patient care.
Clinical trials play a vital role in improving survival rates for patients with pancreatic cancer. At the Jreissati Pancreatic Centre at Epworth, dedicated research teams conduct studies and clinical trials across every stage of cancer diagnosis, treatment, and care.
Their goal is clear: to improve patient outcomes and enhance quality of life for those affected by pancreatic cancer.
About the Jreissati Pancreatic Cancer Centre
Pancreatic cancer remains one of the most difficult cancers to detect and treat. Survival rates are among the lowest of all cancers, and for most patients, early diagnosis is rare. The work being done at the Jreissati Centre at Epworth is helping to change that.
Their dedicated research teams conduct clinical trials across every stage of cancer diagnosis, treatment and care — working to identify better therapies, improve early detection, and ultimately give patients more time and a better quality of life. Clinical trials are the bridge between laboratory discovery and real-world treatment, and funding them is essential.
Why it matters to us
We're an Australian family business. We make things here, we source locally where we can, and we care deeply about the communities we're part of. Supporting meaningful research that helps Australian families isn't separate from what we do — it's an extension of it.
A commitment to giving back is woven into the fabric of our philosophy. Pancreatic cancer touches far too many families. Contributing to the work of the Jreissati Centre, even in a small way, matters deeply to us.
Clinical trials are essential in determining whether new discoveries developed through research can offer better outcomes than current treatment options—bringing hope for more effective therapies in the future.
We're grateful to everyone at the Jreissati Centre for the important work they do every day.
